Abstract
Background
Using fluorescently labeled superoxide dismutase (SOD) and flow cytometry, we have shown previously that the enzyme CuZn SOD (EC 1.15.1.1) from bovine erythrocytes binds rapidly to the cell surface with slow uptake into the cell during the following hours. The degree of labeling was most important for monocytes in comparison to other blood cells (erythrocytes, lymphocytes, and neutrophils) and fibroblasts. In agreement with the flowcytometric findings, the inhibition of superoxide production was more important for SOD-pretreated monocytes than for neutrophils, as demonstrated with the cytochrome c reduction assay. It was thus of interest to confirm the observed differences between monocytes and neutrophils with confocal laser microscopy, study in greater detail the kinetics of binding, penetration, and intracellular localization of the enzyme, and compare the results obtained with bovine CuZn SOD with those from SODs of other origins and carrying different active sites.
Materials and Methods
Recombinant human (rh), bovine, and equine CuZn SODs, as well as rh and E. coli Mn SODs, were studied before use with respect to specific activity and purity (HPLC, SDS-PAGE electrophoresis). Fluorescein isothiocyanate was covalently conjugated to the various SODs for study with high-resolution confocal scanning laser microscopy. Superoxide production by monocytes and neutrophils was measured with the cytochrome c assay.
Results
As expected from our experiments with flow cytometry, only rare neutrophils were labeled with FITC-SOD, even with the longest incubation time of 3 hr and the highest dose of 1500 units/ml. In addition, they showed a localized fluorescence pattern that was quite different from the diffuse punctate fluorescence pattern of monocytes. Lymphocytes were not labeled at all. The rapid binding to the cellular surface of monocytes was confirmed, and even after 5 min of preincubation, FTTC-SOD was found on a small percentage of monocytes. This was correlated with a reduction in superoxide release after phorbolmyristate acetate (PMA) stimulation by 40%. An interesting finding was the perinuclear accumulation of the penetrated SOD after the longest pretreatment of 3 hr, suggesting a barrier against further progression. Indeed, through confocal microscopy we were able to exclude any fluorescence at the nuclear level. While the fluorescence labeling patterns and the kinetics of penetration were quite similar for bovine, equine, and rh CuZn SOD, the Mn SODs showed poor labeling, correlated with a weak inhibitory effect on cytochrome c reduction, which was not statistically significant.
Conclusions
The rapid binding of native CuZn SODs on the surface of monocytes, leading to reduced superoxide release by these cells, explains the observation that beneficial effects of injected SOD lasted for months despite rapid clearance of the enzyme from the bloodstream, according to pharmacodynamic studies. The preferential binding to monocytes, in contrast to neutrophils, may play a role in chronic inflammatory diseases in which the monocytes are in an activated state. The differences in binding capacity between CuZn SODs and Mn SODs, correlated with different inhibitory effects of superoxide production by monocytes, may also have therapeutic significance.
Similar content being viewed by others
References
McCord JM, Fridovich I. (1969) Superoxide dismutase: An enzymatic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244: 6049–6055.
Autor AP. (1982) Pathology of Oxygen. Academic Press, New York.
Huber W, Saifer MGP. (1977) Orgotein, the drug version of bovine CuZn superoxide dismutase: A summary account of safety and pharmacology in laboratory animals. In: Michelson AM, McCord J, Fridovich I (eds). Superoxide and Superoxide Dismutase. Academic Press, London, pp. 517–536.
Lund-Olesen K, Menander KB. (1974) Orgotein: A new anti-inflammatory metalloprotein drug. Preliminary evaluation of clinical efficacy and safety in degenerative joint disease. Curr. Ther. Res. 16: 706–717.
Flohé L. (1988) Superoxide dismutase for therapeutic use: Clinical experience, dead ends and hopes. Mol. Cell. Biochem. 84: 123–131.
Michelson AM, Puget K. (1980) Cell penetration by exogenous superoxide dismutase. Acta Physiol. Scand. 492(Suppl): 67–80.
Ando Y, Inoue M, Utsumi T, Morino Y, Araki S. (1988) Synthesis of acylated SOD derivatives which bind to the biomembrane lipid surface and dismutate extracellular superoxide radicals. FEBS Lett. 240: 216–220.
Dini L, Rotilio G. (1989) Electron microscopic evidence for endocytosis of superoxide dismutase by hepatocytes using protein-gold adducts. Biochem. Biophys. Res. Commun. 162: 940–944.
Kyle ME, Nakae D, Sakaida I, Miccadei S, Färber JL. (1988) Endocytosis of superoxide dismutase is required in order for the enzyme to protect hepatocytes from the cytotoxicity of hydrogen peroxide. J. Biol. Chem. 263: 3784–3789.
Emerit I, Garban F, Vassy J, Levy A, Filipe P, Freitas J. (1996) Superoxide-mediated clastogenesis and anticlastogenic effects of exogenous superoxide dismutase. Proc. Natl. Acad. Sci. U.S.A. 93: 12799–12804.
Lowry OH, Rosebrough NJ, Farr L, Randall RJ. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265–275.
Laemmli UK. (1970) Cleavage of structural proteins during the assembly of the head bacteriophage T-4. Nature 227: 680–685.
Heukeshover J, Dernick R. (1985) Simplified method for silver staining of proteins in Polyacrylamide gels and the mechanism of silver staining. Electrophoresis 6: 103–112.
Johnson RB. (1984) Measurement of O2− secreted by monocytes and macrophages. Methods Enzymol. 105: 215–220.
Takamura Y, Masuda S, Tokuda H, Nishikawa M, Hashida M. (1994) Targeted delivery of superoxide dismutase to macrophages via mannose receptor-mediaed mechanism. Biochem. Pharmacol. 47: 853–858.
Beckman JS, Minor RL, White JE, Rosen GM, Freeman BA. (1988) Superoxide dismutase and catalase conjugated to Polyethylen glycol increases endothelial enzyme activity and oxidant resistance. J. Biol. Chem. 14: 6854–6892.
Dini L, Falasca L, Rossi L, Rotilio G. (1996) In vivo uptake of Cu, Zn superoxide dismutase. Morphological evidence for preferential endocytosis and accumulation by sinusoidal liver cells. Cell. Mol. Biol. 42: 269–277.
Sahgal N, Davis JN, Robbins C, et al. (1996) Localization and activity of recombinant human CuZn superoxide dismutase after intratracheal administration. Am. J. Physiol. 271: L230–L235.
Petkau A, Chelack WS, Kelly K, Friesen HG. (1982) Superoxide dismutase and radiosensitivity: Implications for human mammary carcinomas. In: AP Autor (ed). Pathology of Oxygen. Academic Press, New York, pp. 223–243.
Chatterjee S, Stochai U. (1996) Monitoring nuclear transport in Hela cells using the green fluorescent protein. Bio Techniques 21: 62–63.
Dangeon O, Michelson AM. (1983) Superoxide dismutase: Penetration and intracellular distribution in cells from specific organs. Mol. Physiol. 3: 35–41.
Michelson AM, Jadot G, Puget K. (1987) Mechanism of antiinflammatory activity of superoxide dismutases. In: Hayashi O, Imamura S, Miyachi Y (eds). The Biological Role of Reactive Oxygen Species in Skin. Elsevier, New York, pp. 199–210.
McCord JM, Salin ML. (1977) In: Rossi F, Patriarca P, Romeo D (eds). Movement, Metabolism, and Bactericidal Mechanisms of Phagocytes. Piccin Medical Books, Padova, pp. 257–264.
Steven MM, Lennie SE, Sturrock RD, Gemmel CG. (1984) Enhanced bacterial phagocytosis by pheripheral blood monocytes in rheumatoid arthritis. Ann. Rheum. Dis. 43: 435–439.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Filipe, P., Emerit, I., Vassy, J. et al. Cellular Penetration of Fluorescently Labeled Superoxide Dismutases of Various Origins. Mol Med 5, 517–525 (1999). https://doi.org/10.1007/BF03401979
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03401979